N-SUBSTITUTED HETEROCYCLES FOR THE TREATMENT OF HYPERCHOLESTEREMIA, DYSLIPIDEMIA AND OTHER METABOLIC DISORDERS, CANCER, AND OTHER DISEASES
申请人:Incyte San Diego Incorporated
公开号:EP1456187A1
公开(公告)日:2004-09-15
EP1456187A4
申请人:——
公开号:EP1456187A4
公开(公告)日:2005-02-09
US7071218B2
申请人:——
公开号:US7071218B2
公开(公告)日:2006-07-04
[EN] N-SUBSTITUTED HETEROCYCLES FOR THE TREATMENT OF HYPERCHOLESTEREMIA, DYSLIPIDEMIA AND OTHER METABOLIC DISORDERS, CANCER, AND OTHER DISEASES<br/>[FR] HETEROCYCLES N-SUBSTITUES POUR LE TRAITEMENT DE L'HYPERCHOLESTEROLEMIE, DE LA DYSLIPIDEMIE ET AUTRES TROUBLES DU METABOLISME, DU CANCER ET DE PATHOLOGIES DIVERSES
申请人:MAXIA PHARMACEUTICALS INC
公开号:WO2003043998A1
公开(公告)日:2003-05-30
The present invention relates to certain compounds of Formula (I) which can be useful in the treatment of diseases, such as, cancer, metabolic disorders, Type 2 Diabetes, dyslipidemia and/or hyperchloesterolemia.
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
申请人:——
公开号:US20030144329A1
公开(公告)日:2003-07-31
The present invention relates to certain compounds of Formula (I) which can be useful in the treatment of diseases, such as, cancer, metabolic disorders, Type 2 Diabetes, dyslipidemia and/or hyperchloesterolemia:
1